Achieve Life Sciences Relocates HQ, Reports Officer/Director Changes
Ticker: ACHV · Form: 8-K · Filed: Oct 7, 2025 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $101,296, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, relocation
TL;DR
Achieve Life Sciences moved its HQ to Canada and made exec/board changes.
AI Summary
Achieve Life Sciences, Inc. announced on October 6, 2025, a change in its principal executive offices to Vancouver, BC, Canada. The company also reported on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers.
Why It Matters
This filing indicates significant corporate restructuring and potential changes in leadership and compensation, which could impact the company's strategic direction and operational focus.
Risk Assessment
Risk Level: medium — Changes in executive and director positions, along with a headquarters relocation, can signal strategic shifts or internal challenges that may affect future performance.
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- October 6, 2025 (date) — Date of earliest event reported
- Vancouver, BC, Canada (location) — New principal executive offices
- Delaware (location) — State of Incorporation
- 954343413 (other) — IRS Employer Identification No.
FAQ
What is the new address of Achieve Life Sciences' principal executive offices?
The new principal executive offices are located at 1040 West Georgia, Suite 1030, Vancouver, BC, Canada V6E 4H1.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 6, 2025.
What is the state of incorporation for Achieve Life Sciences, Inc.?
Achieve Life Sciences, Inc. is incorporated in Delaware.
What is the IRS Employer Identification Number for Achieve Life Sciences, Inc.?
The IRS Employer Identification Number is 95-4343413.
What specific items are being reported under Section 13 or 15(d) of the Securities Exchange Act of 1934?
The filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Filing Stats: 718 words · 3 min read · ~2 pages · Grade level 12.7 · Accepted 2025-10-07 16:51:49
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ACHV The Nasdaq Stock Mar
- $101,296 — i) a lump-sum cash severance payment of $101,296, which is equivalent to a prorated port
- $10,000 — ) reimbursement by the Company of up to $10,000 in legal fees incurred by Dr. Jacobs in
Filing Documents
- achv-20251006.htm (8-K) — 50KB
- 0001193125-25-233581.txt ( ) — 193KB
- achv-20251006.xsd (EX-101.SCH) — 50KB
- achv-20251006_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ACHIEVE LIFE SCIENCES, INC. Date: October 7, 2025 /s/ MARK OKI Mark Oki Chief Financial Officer (Principal Financial Officer)